ID-IRC : 1919020112
Benjelloun Soumaya
Docteur (PHD)
Spécialité : Virologie
Institut Pasteur du Maroc - Casablanca
Domaine de Maîtrise :
Épidémiologie et Santé Publique
Domaine d’intérêt :
Épidémiologie et Santé Publique, Essais Cliniques, Recherche Clinique, Biopathologie et Recherche Biomédicale**
Les publications :
https://www.ncbi.nlm.nih.gov/pubmed/?term=Benjelloun%20S%20pasteur%20OR%20Benjelloun%20HEV%20OR%20Soumaya%20Benjelloun%20OR%20Benjelloun%20S%20Tong 1.Jadid FZ, Chihab H, Alj HS, Elfihry R, Zaidane I, Tazi S, Badre W, Marchio A, El Filali KM, Tahiri M, Saile R, Pineau P, Ezzikouri S, Benjelloun S. Control of progression towards liver fibrosis and hepatocellular carcinoma by SOCS3 polymorphisms in chronic HCV-infected patients. Infect Genet Evol. 2018 Dec;66:1-8. 2.Fakhir FZ, Lkhider M, Badre W, Alaoui R, Meurs EF, Pineau P, EzzikouriS, BenjellounS* Genetic variations in toll-like receptors 7 and 8 modulate natural hepatitis C outcomes and liver disease progression. Liver Int. 2018 Mar;38(3):432-442 3.Fakhir FZ, Lkhider M, Badre W, Alaoui R, Meurs EF, Pineau P, EzzikouriS, BenjellounS* Genetic variations in toll-like receptors 7 and 8 modulate natural hepatitis C outcomes and liver disease progression. Liver Int. 2018 , 432-442. 4.Rebbani K, Ababou M, Nadifi S, Kandil M, Marchio A, Pineau P, Ezzikouri S, Benjelloun* S. Myxovirus resistance 1 gene polymorphisms and outcomes of viral hepatitis B and C infections in Moroccan patients. J Med Virol. 2017 Apr;89(4):647-652. doi: 10.1002/jmv.24642. Epub 2016 Dec 26. 5.Fakhir FZ, Lkhider M, Badre W, Alaoui R, Pineau P, Ezzikouri S, Benjelloun S*. The -94Ins/DelATTG polymorphism in NFκB1 promoter modulates chronic hepatitis C and liver disease progression. Infect Genet Evol. 2016 Jan 28;39:141-146. doi: 10.1016/j.meegid.2016.01.023. 6.Rebbani K, Marchio A, Ezzikouri S, Afifi R, Kandil M, Bahri O, Triki H, El Feydi AE, Dejean A, Benjelloun S, Pineau P: TP53 R72P polymorphism modulates DNA methylation in hepatocellular carcinoma. Mol Cancer 2015; 14:74. 7.Rebbani K, Ezzikouri S, Marchio A, Kandil M, Pineau P, Benjelloun S*: MDM2 285G>C and 344T>A gene variants and their association with hepatocellular carcinoma: a Moroccan case-control study. Infect Agent Cancer 2014; 9(1):11. 8.Kitab B, Ezzikouri S, Alaoui R, Nadir S, Badre W, Trepo C, Chemin I, Benjelloun S*: Occult HBV infection in Morocco: from chronic hepatitis to hepatocellular carcinoma. Liver Int 2014; 34(6):e144-150. 9.Ezzikouri S, Alaoui R, Tazi S, Nadir S, Elmdaghri N, Pineau P, Benjelloun S*: The adiponutrin I148M variant is a risk factor for HCV-associated liver cancer in North-African patients. Infect Genet Evol 2014; 21:179-183. 10.Ezzikouri S, Benjelloun S, Pineau P: Human genetic variation and the risk of hepatocellular carcinoma development. Hepatol Int 2013; 7(3):820-831. 11.Ezzikouri S, Alaoui R, Rebbani K, Brahim I, Fakhir FZ, Nadir S, Diepolder H, Khakoo SI, Thursz M, Benjelloun S*: Genetic variation in the interleukin-28B gene is associated with spontaneous clearance and progression of hepatitis C virus in Moroccan patients. Plos One 2013; 8(1):e54793. 12.Akil A, Ezzikouri S, El Feydi AE, Benazzouz M, Afifi R, Diagne AG, Benjouad A, Dejean A, Pineau P, Benjelloun S*: Associations of genetic variants in the transcriptional coactivators EP300 and PCAF with hepatocellular carcinoma. Cancer Epidemiol 2012; 36(5):e300-305. 13.Kitab B, El Feydi AE, Afifi R, Derdabi O, Cherradi Y, Benazzouz M, Rebbani K, Brahim I, Salih Alj H, Zoulim F, Trepo C, Chemin I, Ezzikouri S, Benjelloun S*: Hepatitis B genotypes/subgenotypes and MHR variants among Moroccan chronic carriers. The Journal of infection 2011; 63(1):66-75. 14.Ezzikouri S, Rebbani K, Mostafa A, El Feydi AE, Afifi R, Brahim I, Kitab B, Benazzouz M, Kandil M, Nadifi S, Pineau P, Benjelloun S*: Influence of mutation of the HFE gene on the progression of chronic viral hepatitis B and C in Moroccan patients. J Med Virol 2011; 83(12):2096-2102. 15.Ezzikouri S, Essaid El Feydi A, Afifi R, Benazzouz M, Hassar M, Pineau P, Benjelloun S*: Impact of TP53 codon 72 and MDM2 promoter 309 allelic dosage in a Moroccan population with hepatocellular carcinoma. The International journal of biological markers 2011; 26(4):229-233. 16.Bahri O, Ezzikouri S, Alaya-Bouafif NB, Iguer F, Feydi AE, Mestiri H, Benazzouz M, Khalfallah T, Afifi R, Elkihal L, Berkane S, Marchio A, Debzi N, Dejean A, Pineau P, Triki H, Benjelloun S: First multicenter study for risk factors for hepatocellular carcinoma development in North Africa. World journal of hepatology 2011; 3(1):24-30. 17.Ezzikouri S, El Feydi AE, Afifi R, Benazzouz M, Hassar M, Pineau P, Benjelloun S*: Polymorphisms in antioxidant defence genes and susceptibility to hepatocellular carcinoma in a Moroccan population. Free Radic Res 2010; 44(2):208-216. 18.Ezzikouri S, El Feydi AE, Benazzouz M, Afifi R, El Kihal L, Hassar M, Akil A, Pineau P, Benjelloun S*: Single nucleotide polymorphism in DNMT3B promoter and its association with hepatocellular carcinoma in a Moroccan population. Infect Genet Evol 2009; 9(5):877-881. 19.Ezzikouri S, El Feydi AE, Afifi R, El Kihal L, Benazzouz M, Hassar M, Marchio A, Pineau P, Benjelloun S*: MDM2 SNP309T>G polymorphism and risk of hepatocellular carcinoma: a case-control analysis in a Moroccan population. Cancer Detect Prev 2009; 32(5-6):380-385. 20.Ezzikouri S, El Feydi AE, El Kihal L, Afifi R, Benazzouz M, Hassar M, Chafik A, Pineau P, Benjelloun S*: Prevalence of common HFE and SERPINA1 mutations in patients with hepatocellular carcinoma in a Moroccan population. Arch Med Res 2008; 39(2):236-241. 21.Ezzikouri S, El Feydi AE, Chafik A, Afifi R, El Kihal L, Benazzouz M, Hassar M, Pineau P, Benjelloun S*: Genetic polymorphism in the manganese superoxide dismutase gene is associated with an increased risk for hepatocellular carcinoma in HCV-infected Moroccan patients. Mutation research 2008; 649(1-2):1-6. 22.Pineau P, Ezzikouri S, Marchio A, Benazzouz M, Cordina E, Afifi R, Elkihal L, Khalfallah MT, Mestiri H, Tebbal S, Berkane S, Debzi N, Triki H, Dejean A, Iguer F, Bahri O, Essaid El Feydi AE, Benjelloun S: Genomic stability prevails in North-African hepatocellular carcinomas. Digestive and liver disease 2007; 39(7):671-677. 23.Ezzikouri S, El Feydi AE, Chafik A, Benazzouz M, El Kihal L, Afifi R, Hassar M, Pineau P, Benjelloun S*: The Pro variant of the p53 codon 72 polymorphism is associated with hepatocellular carcinoma in Moroccan population. Hepatol Res 2007; 37(9):748-754. 24.Olivier Galy, Marie-Anne Petit, Soumaya Benjelloun, Philippe Chevallier, Michelle Chevallier, Petcharin Srivatanakul, Anant Karalak, Christine Carreira, Nicole Lyandrat, Abdellah Essaid, Christian Trepo, Pierre Hainaut, Isabelle Chemin. Efficient hepatitis C antigen immunohistological staining in sections of normal, cirrhotic and tumoral liver using a new monoclonal antibody directed against serum-derived HCV E2 glycoproteins. Cancer Letters. 2007, 248: 81-88